Onicomicosis por hongos filamentosos no dermatofitos
Palacio, Amalia Del; Pazos, Carmen; Cuétara, Soledad.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 19(9): 439-442, nov. 2001.
Artículo en Es | IBECS (España) | ID: ibc-2975
Documentos relacionados
Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
Safety assessment for nail cosmetics: Framework for the estimation of systemic exposure through the nail plate.
Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.
Relevant insights into onychomycosis' pathogenesis related to the effectiveness topical treatment.
Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for Onychomycosis.
From the Cochrane library: Topical and device-based treatments for fungal infections of the toenails.
Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
The Penetrance of Topical Nail Therapy: Limitations and Current Enhancements.